These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31685778)

  • 1. Anti-proliferative Activities of Some Bivalent Symmetrical 5-Substituted Hydantoin Derivatives towards Human Brain Glioma U251 Cells (U251) and Human Carcinoma Cells (KB3-1).
    Furutachi M; Ota K; Fujisaki F; Ikeda R; Yoshikawa N; Yokota T; Takeda Y; Yokomizo K; Zhou JR; Kashige N; Miake F; Sumoto K
    Biol Pharm Bull; 2019; 42(11):1953-1956. PubMed ID: 31685778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-proliferative Activities towards Human Brain Glioma U251 Cells and Human Carcinoma Cells (KB3-1) of Some Twin-Drug Type Bivalent C
    Furutachi M; Gondo T; Ikeda R; Yoshikawa N; Yokota T; Takeda Y; Yokomizo K; Zhou JR; Kashige N; Miake F; Sumoto K
    Biol Pharm Bull; 2019; 42(5):833-836. PubMed ID: 31061327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of new 5-substituted hydantoins and symmetrical twin-drug type hydantoin derivatives.
    Fujisaki F; Aki H; Naito A; Fukami E; Kashige N; Miake F; Sumoto K
    Chem Pharm Bull (Tokyo); 2014; 62(5):429-38. PubMed ID: 24789925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydantoin derivatives of L- and D-amino acids: synthesis and evaluation of their antiviral and antitumoral activity.
    Rajic Z; Zorc B; Raic-Malic S; Ester K; Kralj M; Pavelic K; Balzarini J; De Clercq E; Mintas M
    Molecules; 2006 Nov; 11(11):837-48. PubMed ID: 18007390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Tumor Mechanisms of Novel 3-(4-Substituted Benzyl)-5-Isopropil-5- Phenylhydantoin Derivatives in Human Colon Cancer Cell Line.
    Obradović A; Matić M; Ognjanović B; Vuković N; Vukić M; Đurđević P; Ušćumlić G; Božić B; Nedeljković BB
    Anticancer Agents Med Chem; 2019; 19(12):1491-1502. PubMed ID: 31840594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor and anti-angiogenic activity of novel hydantoin derivatives: Inhibition of VEGF secretion in liver metastatic osteosarcoma cells.
    Basappa ; Ananda Kumar CS; Nanjunda Swamy S; Sugahara K; Rangappa KS
    Bioorg Med Chem; 2009 Jul; 17(14):4928-34. PubMed ID: 19556138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents.
    Zhang M; Liang YR; Li H; Liu MM; Wang Y
    Bioorg Med Chem; 2017 Dec; 25(24):6623-6634. PubMed ID: 29126741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: a SAR study.
    Ananda Kumar CS; Kavitha CV; Vinaya K; Benaka Prasad SB; Thimmegowda NR; Chandrappa S; Raghavan SC; Rangappa KS
    Invest New Drugs; 2009 Aug; 27(4):327-37. PubMed ID: 18839066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line.
    Zuliani V; Carmi C; Rivara M; Fantini M; Lodola A; Vacondio F; Bordi F; Plazzi PV; Cavazzoni A; Galetti M; Alfieri RR; Petronini PG; Mor M
    Eur J Med Chem; 2009 Sep; 44(9):3471-9. PubMed ID: 19268405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of some 5-dialkylaminomethylhydantoins and related derivatives.
    Fujisaki F; Toyofuku K; Egami M; Ishida S; Nakamoto N; Kashige N; Miake F; Sumoto K
    Chem Pharm Bull (Tokyo); 2013; 61(10):1090-3. PubMed ID: 24088702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery, design, and synthesis of anti-metastatic lead phenylmethylene hydantoins inspired by marine natural products.
    Mudit M; Khanfar M; Muralidharan A; Thomas S; Shah GV; van Soest RW; El Sayed KA
    Bioorg Med Chem; 2009 Feb; 17(4):1731-8. PubMed ID: 19195897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum(IV) complexes with some derivatives of 5-methyl-5-(4-pyridyl) hydantoin. Synthesis, study and comparative pharmacological investigation.
    Bakalova A; Buyukliev R; Ivanova Z; Momekov G; Ivanov D
    Drug Res (Stuttg); 2013 Aug; 63(8):420-3. PubMed ID: 23677699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Anticancer Evaluation and Docking Study of 3- Benzyloxyhydantoin Derivatives.
    Liu J; Zhang K; Mai X; Wei J; Liao Y; Zhong Y; Liu Y; Feng L; Liu C
    Med Chem; 2016; 12(1):37-47. PubMed ID: 26152144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the Synthesis, Characterization and Bioactivities of 3-Methyl-9'-fluorenespiro-5-hydantoin.
    Marinova P; Marinov M; Kazakova M; Feodorova Y; Slavchev A; Blazheva D; Georgiev D; Penchev P; Sarafian V; Stoyanov N
    Acta Chim Slov; 2016; 63(1):26-32. PubMed ID: 26970785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents.
    Azizmohammadi M; Khoobi M; Ramazani A; Emami S; Zarrin A; Firuzi O; Miri R; Shafiee A
    Eur J Med Chem; 2013 Jan; 59():15-22. PubMed ID: 23202485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure-activity relationship study.
    Ananda Kumar CS; Prasad SB; Vinaya K; Chandrappa S; Thimmegowda NR; Ranganatha SR; Swarup S; Rangappa KS
    Invest New Drugs; 2009 Apr; 27(2):131-9. PubMed ID: 18607541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of multidrug efflux pump activity by new hydantoin derivatives on colon adenocarcinoma cells without inducing apoptosis.
    Spengler G; Handzlik J; Ocsovszki I; Viveiros M; Kiec-Kononowicz K; Molnar J; Amaral L
    Anticancer Res; 2011 Oct; 31(10):3285-8. PubMed ID: 21965738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and anticancer evaluation of tetrahydro-β-carboline-hydantoin hybrids.
    Shankaraiah N; Nekkanti S; Chudasama KJ; Senwar KR; Sharma P; Jeengar MK; Naidu VG; Srinivasulu V; Srinivasulu G; Kamal A
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5413-7. PubMed ID: 25453799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.